![](/img/cover-not-exists.png)
PCN259 SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY
Hatswell, A.J., Bullement, A., Schlichting, M., Bharmal, M.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.380
Date:
May, 2019
File:
PDF, 379 KB
english, 2019